The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Use of Nucleoside Reverse Transcriptase Inhibitors Sparing Regimens in Treatment-Experienced HIV-1 Infected Patients

Published:2013-06-01 Issue:3 Volume:11 Page:179-186
ISSN:1570-162X
Container-title:Current HIV Research
language:en
Short-container-title:CHR

Author:

Biagio Antonio,Ricci Elena,Viscoli Claudio,Mesini Alessio,Menzaghi Barbara,Carenzi Laura,Orofino Giancarlo,Parruti Giustino,Martinelli Canio,Madeddu Giordano,De Socio Giuseppe,Franzetti Marco,Quirino Tiziana,Paolo Bonfanti on behalf of the CISAI Group Paolo

Publisher

Bentham Science Publishers Ltd.

Subject

Virology,Infectious Diseases

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients;Journal of the International Association of Providers of AIDS Care (JIAPAC);2019-01-01

2. Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL;Infection;2017-05-05

3. The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor;Current Clinical Pharmacology;2016-08-01

4. Brief Report;JAIDS Journal of Acquired Immune Deficiency Syndromes;2016-04-15

5. HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors;Annals of Internal Medicine;2015-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP